Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension

Samantha Cruz Rivera(University of Birmingham), Samuel Rowley(MRC Clinical Trials Unit at UCL), Jonathan J Deeks(Birmingham City University), Hugh Harvey(United States Food and Drug Administration), M. Khair ElZarrad(Center for Drug Evaluation and Research), Lavinia Ferrante di Ruffano(University of Applied Health Sciences), Adrian Jonas(University of Toronto), Aaron Lee(Imperial College London), Cynthia D. Mulrow(The University of Texas at San Antonio Health Science Center), John Fletcher(University of Birmingham), Robert Golub(American Medical Association), Xiaoxuan Liu(University Hospitals Birmingham NHS Foundation Trust), Livia Faes(Moorfields Eye Hospital NHS Foundation Trust), Hutan Ashrafian(NIHR Imperial Biomedical Research Centre), An‐Wen Chan(World Health Organization), Ara Darzi(Imperial College Healthcare NHS Trust), Gary S. Collins(NIHR Birmingham Biomedical Research Centre), Dina N. Paltoo(National Institutes of Health), Melissa D. McCradden(3M (United States)), Charlotte Haug, Cecilia S. Lee(University of Washington), David Moher(University of Ottawa), Andre Esteva(Artistic Realization Technologies), Maria Beatrice Panico(University of Rome Tor Vergata), Melanie Calvert(NIHR Birmingham Biomedical Research Centre), Alastair K. Denniston(UK Biobank), Andrew L. Beam(Harvard University), Elaine Manna(The Patients Association), Christopher Yau(Turing Institute), Richard S. Savage(Bridgepoint (United Kingdom)), João Monteiro(The Nature Conservancy), Rupa Sarkar, Christopher Holmes(University of Oxford), Christophe J. Kelly(Birmingham Community Healthcare NHS Trust), James Matcham(Goethe University Frankfurt), Gary Price(AstraZeneca (United Kingdom)), Sebastian J. Vollmer(National Institute for Health and Care Excellence), Luke Oakden‐Rayner(Royal Adelaide Hospital), Cyrus Espinoza(Birmingham Community Healthcare NHS Trust)
Nature Medicine
September 1, 2020
Cited by 665


Related Papers